Stephen Martin to Opiate Substitution Treatment
This is a "connection" page, showing publications Stephen Martin has written about Opiate Substitution Treatment.
Connection Strength
2.175
-
Chan B, Cook R, Levander X, Wiest K, Hoffman K, Pertl K, Petluri R, McCarty D, Korthuis PT, Martin SA. Buprenorphine discontinuation in telehealth-only treatment for opioid use disorder: A longitudinal cohort analysis. J Subst Use Addict Treat. 2024 Dec; 167:209511.
Score: 0.802
-
Martin SA, Chiodo LM, Bosse JD, Wilson A. The Next Stage of Buprenorphine Care for Opioid Use Disorder. Ann Intern Med. 2018 11 06; 169(9):628-635.
Score: 0.534
-
Grande LA, Hutch T, Jack K, Mironov W, Iwuoha J, Muy-Rivera M, Grillo J, Martin SA, Herring A. Ketamine-assisted buprenorphine initiation: a pilot case series. Addict Sci Clin Pract. 2024 Aug 29; 19(1):60.
Score: 0.200
-
Randall A, Hull I, Martin SA. Enhancing Patient Choice: Using Self-administered Intranasal Naloxone for Novel Rapid Buprenorphine Initiation. J Addict Med. 2023 Mar-Apr 01; 17(2):237-240.
Score: 0.175
-
Martin SA, Chiodo LM, Wilson A. Common Misperceptions About Buprenorphine Prescribing for Opioid Use Disorder. Am Fam Physician. 2019 10 01; 100(7):396-397.
Score: 0.143
-
Martin SA, Chiodo LM, Wilson A. Retention in care as a quality measure for opioid use disorder. Subst Abus. 2019; 40(4):453-458.
Score: 0.141
-
Martin SA, Chiodo LM, Bosse JD, Wilson A. The Next Stage of Buprenorphine Care for Opioid Use Disorder. Ann Intern Med. 2019 06 04; 170(11):821-822.
Score: 0.139
-
Anderson JB, Martin SA, Gadomski A, Krupa N, Mullin D, Cahill A, Jenkins P. Project ECHO and primary care buprenorphine treatment for opioid use disorder: Implementation and clinical outcomes. Subst Abus. 2022; 43(1):222-230.
Score: 0.040